Popular on TelAve
- Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network - 216
- AeroNet Deploys netElastic vBNG and CGNAT with Tarana Wireless to Deliver Scalable, Fiber-Class Broadband Across Puerto Rico - 185
- One in three Americans may have lost track of retirement savings from a previous job - 150
- AI Voice Agents Are Now Calling AI Receptionists, NextPhone 2026 Call Report Finds - 122
- 1569531 B.C. LTD. dba ELEOLUXE Connects Renovation Design and Project Coordination - 116
- Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth - 110
- RAS AP Consulting Advances 1099 Education and Readiness Initiative Through IFOL Training and Finance Technology Showcase - 107
- KAIT to Demonstrate 400 Gbps 8K Video Processing via SRv6 In-Network Computing at SC26 - 103
- Local Fiber Rebrands as BroadX, Expanding Its Broadband Distribution Platform - 103
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
Transtek Supports Diabetes Management with Connected Blood Glucose Monitoring Solutions
TelAve News/10912629
ZHONGSHAN, China - TelAve -- Diabetes management requires regular blood glucose monitoring to help patients and healthcare providers track glucose levels and make informed care decisions. With World Diabetes Day drawing attention to the global impact of diabetes each November, Transtek highlights its existing range of connected blood glucose monitoring devices and their role in remote patient monitoring (RPM) programs.
According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20–79 were living with diabetes in 2024. This figure is projected to reach 853 million by 2050. The IDF also estimates that 252 million adults with diabetes remain undiagnosed, highlighting the importance of greater awareness, early screening, and appropriate medical care.
For people living with diabetes, regular blood glucose measurements provide useful information for tracking glucose levels and reviewing how daily activities and treatment may affect them. For healthcare providers, obtaining these readings outside clinical settings can help extend monitoring beyond scheduled visits. However, collecting measurements and transferring them to healthcare teams can add steps to both patient routines and provider workflows.
More on TelAve News
To support these needs, Transtek offers cellular and Bluetooth-enabled blood glucose monitoring devices for different RPM deployment requirements.
The TeleRPM BGM Gen 1 Cellular Blood Glucose Monitor features built-in 4G connectivity and supports AT&T, T-Mobile, and Verizon networks. It automatically transmits glucose readings without requiring patients to pair the meter with a smartphone, install an app, or configure a Wi-Fi connection.
For Bluetooth-based deployments, the TeleRPM Bluetooth Blood Glucose Monitor connects to the TeleRPM AnyHub, which uses built-in 4G connectivity to transmit measurement results. This configuration allows healthcare providers to incorporate blood glucose monitoring into multi-device RPM programs.
More on TelAve News
The blood glucose monitoring solutions use single-layer, 8-electrode test strips with hematocrit correction across a range of 20%–70%. The meter requires a 0.8 μL blood sample and delivers results in approximately five seconds, supporting routine blood glucose testing.
In addition to its blood glucose monitoring devices, Transtek provides Device Management Dashboards and fulfillment services to support healthcare providers with device deployment and RPM operations.
As diabetes continues to affect a growing global population, reliable blood glucose monitoring remains an important part of disease management. Transtek continues to provide connected medical devices and supporting services for partners developing and managing RPM programs.
About Transtek
Founded in 2002, Transtek provides medical devices and solutions for remote patient monitoring, combining medical-grade devices, connectivity technology, Device Management Dashboards, and fulfillment services to support telehealth partners and healthcare providers.
According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20–79 were living with diabetes in 2024. This figure is projected to reach 853 million by 2050. The IDF also estimates that 252 million adults with diabetes remain undiagnosed, highlighting the importance of greater awareness, early screening, and appropriate medical care.
For people living with diabetes, regular blood glucose measurements provide useful information for tracking glucose levels and reviewing how daily activities and treatment may affect them. For healthcare providers, obtaining these readings outside clinical settings can help extend monitoring beyond scheduled visits. However, collecting measurements and transferring them to healthcare teams can add steps to both patient routines and provider workflows.
More on TelAve News
- Montana Artist Ryan Jolley Receives Goodman Award at Mountain Oyster Club Art Show
- Make Your Move to Luxury Living at Heritage at Hopewell with Rates Starting at Just 3.750% (5.803% APR)
- Scott Glickson Joins STS Capital Partners as Managing Director
- BREAKTHROUGH TROP2 Research Reveals New REQORSA® Opportunities as Roche Collaboration Strengthens Precision Lung Cancer Strategy
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Dallas–Fort Worth
To support these needs, Transtek offers cellular and Bluetooth-enabled blood glucose monitoring devices for different RPM deployment requirements.
The TeleRPM BGM Gen 1 Cellular Blood Glucose Monitor features built-in 4G connectivity and supports AT&T, T-Mobile, and Verizon networks. It automatically transmits glucose readings without requiring patients to pair the meter with a smartphone, install an app, or configure a Wi-Fi connection.
For Bluetooth-based deployments, the TeleRPM Bluetooth Blood Glucose Monitor connects to the TeleRPM AnyHub, which uses built-in 4G connectivity to transmit measurement results. This configuration allows healthcare providers to incorporate blood glucose monitoring into multi-device RPM programs.
More on TelAve News
- BroadX partners with CommSoft to expand sales channels for broadband providers
- BroadX connects with Sonar to help internet providers expand their sales reach
- PinnacleQM launches new enterprise website to help Australian organisations deliver more with confidence
- Loud! OOH Launches UK's First Free Planning Tool for UK Outdoor Advertising Budgets
- Boston Industrial Solutions Introduces the New Volta® M100 Pad Printing Machine
The blood glucose monitoring solutions use single-layer, 8-electrode test strips with hematocrit correction across a range of 20%–70%. The meter requires a 0.8 μL blood sample and delivers results in approximately five seconds, supporting routine blood glucose testing.
In addition to its blood glucose monitoring devices, Transtek provides Device Management Dashboards and fulfillment services to support healthcare providers with device deployment and RPM operations.
As diabetes continues to affect a growing global population, reliable blood glucose monitoring remains an important part of disease management. Transtek continues to provide connected medical devices and supporting services for partners developing and managing RPM programs.
About Transtek
Founded in 2002, Transtek provides medical devices and solutions for remote patient monitoring, combining medical-grade devices, connectivity technology, Device Management Dashboards, and fulfillment services to support telehealth partners and healthcare providers.
Source: Guangdong Transtek Medical Electronics Co., Ltd.
0 Comments
Latest on TelAve News
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
- LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Kitchen Table Economics: An Invitation to Think Differently
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Cellhire strengthens IoT team with two new appointments as demand grows
- ViewDNS.info Launches Monitors, Alerting Teams the Moment Something Changes on Their Domains
